BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37984993)

  • 21. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
    Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
    Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
    [No Abstract]   [Full Text] [Related]  

  • 22. CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis.
    Zhou X; Meng F; Xiao L; Shen H
    BMC Med Genomics; 2023 Oct; 16(1):228. PubMed ID: 37784135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.
    Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C
    Front Oncol; 2021; 11():626961. PubMed ID: 33747944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-
    Chen Q; Du X; Hu S; Huang Q
    Biomed Res Int; 2022; 2022():5092505. PubMed ID: 35036435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
    Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
    Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of nucleotide metabolism and neuroendocrine regulation-associated modification patterns in stomach adenocarcinoma with auxiliary prognostic assessment and immunotherapy response prediction.
    Zhang Y; Zeng L; Lin D; Chang G; Zeng Y; Xia Y
    Front Endocrinol (Lausanne); 2022; 13():1076521. PubMed ID: 36726460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
    Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
    Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
    Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
    Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Wang H; Tian Y; Li T; Zhang W; Ma L; Chen X; Wei Y
    Lipids Health Dis; 2023 Dec; 22(1):212. PubMed ID: 38042786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
    Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
    Front Immunol; 2022; 13():951214. PubMed ID: 35967313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 38. An Activated Dendritic-Cell-Related Gene Signature Indicative of Disease Prognosis and Chemotherapy and Immunotherapy Response in Colon Cancer Patients.
    Ouyang Y; Yu M; Liu T; Suo M; Qiao J; Wang L; Li N
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures.
    Han X; Lu H; Tang X; Zhao Y; Liu H
    Immun Inflamm Dis; 2022 Jan; 10(1):43-59. PubMed ID: 34582114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    Shen K; Chen B; Gao W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.